Company Profile Boards & Staffs Memberships & Partners Academy of Journalism Careers Blog(EN)Contact Us

Our Journals Instruction for Authors Brieflands Policies Publish My Research Journal Management System Article Processing Charges Open Peer Review Publishing Services

Publish My Book

Scopus by Title (Ref)

1. Low-Dose vs Standard-Dose Valganciclovir for Cytomegalovirus Prophylaxis After Kidney Transplantation: A Single-Center Retrospective Analysis

- Farkas K. , et al.

2. Cytomegalovirus drug resistance mutations in transplant recipients with suspected resistance

- Recio V. , et al.

3. Cytomegalovirus and other herpesviruses after hematopoietic cell and solid organ transplantation: From antiviral drugs to virus-specific T cells

- Ivana T. , et al.

4. Cytomegalovirus UL97 ganciclovir resistance mutations in kidney transplant recipients

- Mina T. , et al.

5. Investigation of ganciclovir resistance in cytomegalovirus strains obtained from immunocompromised patients

- Coşkun A. , et al.

6. Global estimate of phenotypic and genotypic ganciclovir resistance in cytomegalovirus infections among HIV and organ transplant patients; A systematic review and meta-analysis

- Azimi T. , et al.

7. Risk factors for failure of primary (val)ganciclovir prophylaxis against cytomegalovirus infection and disease in solid organ transplant recipients

- Khurana M. , et al.

8. Persistent Primary Cytomegalovirus Infection After Deceased Donor Kidney Transplant: Ganciclovir Susceptibility of Human Cytomegalovirus With UL97 D605E Mutation: A Case Report

- Nawashiro Y. , et al.